1. Recombinant Capital. http://www.recap.com
2. Burrill, S. Biotech 2002: Life Sciences: System Biology Industry Report (Burrill & Co, San Francisco, CA, 2002).
3. Nicholson, S., Danzon, P.M., & McCullough, J. Biotech–Pharmaceutical Alliances as a Signal of Asset and Firm Quality. National Bureau of Economic Research. Working Paper w9007 (January 2002). http://www.nber.org/papers/w9007
4. Katz, M. & Shapiro, C. R&D rivalry with licensing or imitation. Am. Econ. Rev. 77, 402 (1997).
5. Waterman, R. What America Does Right: Learning from Companies that Put People First (W.W. Norton & Co., New York, 1994).